Experimental myasthenia gravis in congenic mice. Sequence mapping and H-2 restriction of T helper epitopes on the alpha subunits of Torpedo californica and murine acetylcholine receptors
- PMID: 1680694
- DOI: 10.1002/eji.1830211003
Experimental myasthenia gravis in congenic mice. Sequence mapping and H-2 restriction of T helper epitopes on the alpha subunits of Torpedo californica and murine acetylcholine receptors
Abstract
Immunization of mice with nicotinic acetylcholine receptor from Torpedo electric organ (TAChR) causes a disease similar to human myasthenia gravis (experimental autoimmune myasthenia gravis, EAMG). Susceptibility to EAMG correlates with the H-2 haplotype. In this study we used overlapping synthetic peptide corresponding to the complete sequences of the alpha subunits from TAChR and murine muscle AChR (MAChR) to map T helper epitopes in congenic murine strains of different H-2 haplotype. C57BL/6 and BALB/B mice (highly susceptible to EAMG) and BALB/c and CB17 mice (less susceptible to EAMG), immunized with TAChR, developed similar anti-TAChR antibody titers and L3T4+ (T helper) cell sensitization. Different sequence segments of the TAChR alpha subunit were recognized by L3T4+ cells from strains of H-2b and H-2d haplotype. The sequence segments recognized by the H-2d strains have the highest predicted propensity to form amphipatic alpha helices, while those recognized by the H-2b strains do not. We investigated whether in EAMG T helper cells cross-react with autologous AChR sequences, and a true break of the tolerance occurs. Overlapping synthetic peptides, corresponding to the complete sequence of MAChR alpha subunit, were used to test L3T4+ cell from mice immunized with TAChR. L3T4+ cell strains did not cross-react with any murine peptide sequence, while L3T4+ cells from H-2d mice were strongly stimulated by the peptide sequence Ma alpha 304-322, which is very similar to the homologous Torpedo peptide.
Similar articles
-
The I-Abm12 mutation, which confers resistance to experimental myasthenia gravis, drastically affects the epitope repertoire of murine CD4+ cells sensitized to nicotinic acetylcholine receptor.J Immunol. 1991 Sep 1;147(5):1484-91. J Immunol. 1991. PMID: 1715360
-
B-cell activation in vitro by helper T cells specific to region alpha 146-162 of Torpedo californica nicotinic acetylcholine receptor.J Immunol. 1996 Oct 1;157(7):3192-9. J Immunol. 1996. PMID: 8816433
-
Cryptic epitopes on the nicotinic acetylcholine receptor are recognized by autoreactive CD4+ cells.J Immunol. 1993 Jul 15;151(2):1025-38. J Immunol. 1993. PMID: 7687612
-
Autoimmune responses against acetylcholine receptor: T and B cell collaboration and manipulation by synthetic peptides.Crit Rev Immunol. 1997;17(5-6):481-95. Crit Rev Immunol. 1997. PMID: 9419435 Review.
-
On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope.Crit Rev Immunol. 2001;21(1-3):1-27. Crit Rev Immunol. 2001. PMID: 11642597 Review.
Cited by
-
Mapping myasthenia gravis-associated T cell epitopes on human acetylcholine receptors in HLA transgenic mice.J Clin Invest. 2002 Apr;109(8):1111-20. doi: 10.1172/JCI14255. J Clin Invest. 2002. PMID: 11956249 Free PMC article.
-
Neuronal survival after CNS insult is determined by a genetically encoded autoimmune response.J Neurosci. 2001 Jul 1;21(13):4564-71. doi: 10.1523/JNEUROSCI.21-13-04564.2001. J Neurosci. 2001. PMID: 11425884 Free PMC article.
-
Myasthenia gravis. CD4+ T epitopes on the embryonic gamma subunit of human muscle acetylcholine receptor.J Clin Invest. 1992 Oct;90(4):1558-67. doi: 10.1172/JCI116024. J Clin Invest. 1992. PMID: 1383275 Free PMC article.
-
Recombinant IgG2a Fc (M045) multimers effectively suppress experimental autoimmune myasthenia gravis.J Autoimmun. 2014 Aug;52:64-73. doi: 10.1016/j.jaut.2013.12.014. Epub 2014 Jan 2. J Autoimmun. 2014. PMID: 24388113 Free PMC article.
-
C57BL/6 mice genetically deficient in IL-12/IL-23 and IFN-gamma are susceptible to experimental autoimmune myasthenia gravis, suggesting a pathogenic role of non-Th1 cells.J Immunol. 2007 Jun 1;178(11):7072-80. doi: 10.4049/jimmunol.178.11.7072. J Immunol. 2007. PMID: 17513756 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical